Literature DB >> 12732179

Cbf beta is involved in maturation of all lineages of hematopoietic cells during embryogenesis except erythroid.

Mondira Kundu1, P Paul Liu.   

Abstract

The transcription factor Cbf beta forms a heterodimeric complex with members of the Runx family of proteins. Together, Cbf beta and Runx1 play a critical role in the establishment of definitive hematopoiesis in mouse embryos. Previously, we used a Cbfb-GFP "knock-in" mouse model to demonstrate that Cbf beta is expressed in hematopoietic stem cells of the mouse fetal liver and aorta-gonad-mesonephros (Blood 100 (2002), 2449). We also examined the expression pattern of Cbf beta in different lineages of adult hematopoietic cells and found that it is expressed uniformly in all lineages except B lymphocytes and erythroid cells. Cbf beta expression decreases during maturation of B cells in the adult bone marrow, and is not expressed in nucleated erythroid precursors. Here, we examine the expression of Cbf beta in various hematopoietic lineages, including myeloid, lymphoid, and erythroid during late stages of embryonic development, and compare it to the pattern observed in adults. We find that there are subtle differences in expression of Cbf beta-GFP in embryonic hematopoietic cells compared to their adult counterparts, but that the overall pattern is the same. Our data complement recently published data on hematopoetic defects observed in transgenic Cbfb-null mouse embryos partially rescued by ectopic expression of Cbfb (Nature Genet. 32 (2002), 633; Nature Genet. 32 (2002), 645). and supports the emerging view that Cbf beta and Runx proteins are required for normal maturation of hematopoietic cells as well as establishment of definitive hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732179     DOI: 10.1016/s1079-9796(03)00030-5

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  7 in total

Review 1.  Hemangioblasts representing a functional endothelio-hematopoietic entity in ontogeny, postnatal life, and CML neovasculogenesis.

Authors:  Gregor Prindull
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

2.  Corepressor Rcor1 is essential for murine erythropoiesis.

Authors:  Huilan Yao; Devorah C Goldman; Tamilla Nechiporuk; Sunita Kawane; Shannon K McWeeney; Jeffrey W Tyner; Guang Fan; Marc A Kerenyi; Stuart H Orkin; William H Fleming; Gail Mandel
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

3.  CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus.

Authors:  Ling Zhao; Jennifer L Cannons; Stacie Anderson; Martha Kirby; Liping Xu; Lucio H Castilla; Pamela L Schwartzberg; Rémy Bosselut; P Paul Liu
Journal:  Blood       Date:  2006-12-21       Impact factor: 22.113

4.  MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA.

Authors:  Marina Bousquet; Diu Nguyen; Cynthia Chen; Lauren Shields; Harvey F Lodish
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

5.  Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype.

Authors:  Joseph D Growney; Hirokazu Shigematsu; Zhe Li; Benjamin H Lee; Jennifer Adelsperger; Rebecca Rowan; David P Curley; Jeffery L Kutok; Koichi Akashi; Ifor R Williams; Nancy A Speck; D Gary Gilliland
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

6.  Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development.

Authors:  Hui Huang; Ming Yu; Thomas E Akie; Tyler B Moran; Andrew J Woo; Nathan Tu; Zachary Waldon; Yin Yin Lin; Hanno Steen; Alan B Cantor
Journal:  Mol Cell Biol       Date:  2009-05-26       Impact factor: 4.272

7.  Evidence for diversity in transcriptional profiles of single hematopoietic stem cells.

Authors:  Carlos A Ramos; Teresa A Bowman; Nathan C Boles; Akil A Merchant; Yayun Zheng; Irma Parra; Suzanne A W Fuqua; Chad A Shaw; Margaret A Goodell
Journal:  PLoS Genet       Date:  2006-08-09       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.